A review of cognitive impairment and cerebral metabolite abnormalities in patients with hepatitis C infection

Daniel M Forton,Joanna M Allsop,I Jane Cox,Gavin Hamilton,Keith Wesnes,Howard C Thomas,Simon D Taylor-Robinson
DOI: https://doi.org/10.1097/01.aids.0000192071.72948.77
IF: 4.632
2005-10-01
AIDS
Abstract:Numerous studies have reported associations between chronic hepatitis C virus (HCV) infection and fatigue, depression and impairments in health-related quality of life, which are independent of the severity of liver disease. Although there are a large number of potential explanations for these symptoms, including a history of substance abuse and associated personality types, or the effect of the diagnosis of HCV infection itself, there has been recent interest in the possibility of a biological effect of HCV infection on cerebral function. There is emerging evidence of mild, but significant neurocognitive impairment in HCV infection, which cannot be wholly attributed to substance abuse, co-existent depression or hepatic encephalopathy. Impairments are predominantly in the domains of attention, concentration and information processing speed. Furthermore, in-vivo cerebral magnetic resonance spectroscopy studies in patients with hepatitis C and normal liver function have reported elevations in cerebral choline-containing compounds and reductions in N-acetyl aspartate, suggesting that a biological mechanism may underlie the cognitive findings. The recent detection of HCV genetic sequences in post-mortem brain tissue raises the intriguing possibility that HCV infection of the central nervous system may be related to the reported neuropsychological symptoms and cognitive impairment.
immunology,infectious diseases,virology
What problem does this paper attempt to address?